Por motivos de mantenimiento se ha deshabilitado el inicio de sesión temporalmente. Rogamos disculpen las molestias.
Artículo
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia
Autor/es | Pérez Nadales, Elena
Gutiérrez Gutiérrez, Belén Natera, Alejandra M. Abdala, Edson Magalhães, Maira Reina Mularoni, Alessandra Pascual Hernández, Álvaro Rodríguez-Baño, Jesús Cordero Matia, María Elisa Lepe Jiménez, José Antonio REIPI/INCREMENT-SOT Investigators |
Director | |
Departamento | Universidad de Sevilla. Departamento de Medicina Universidad de Sevilla. Departamento de Microbiología |
Fecha de publicación | 2020 |
Fecha de depósito | 2024-04-08 |
Publicado en |
|
Resumen | Treatment of carbapenemase-producing Enterobacterales bloodstream infections
in solid organ transplant recipients is challenging. The objective of this study was
to develop a specific score to predict mortality in solid ... Treatment of carbapenemase-producing Enterobacterales bloodstream infections in solid organ transplant recipients is challenging. The objective of this study was to develop a specific score to predict mortality in solid organ transplant recipients with carbapenemase-producing Enterobacterales bloodstream infections. A multina- tional, retrospective (2004-2016) cohort study (INCREMENT-SOT, ClinicalTrials.gov NCT02852902) was performed. The main outcome variable was 30-day all-cause mortality. The INCREMENT-SOT-CPE score was developed using logistic regression. Theglobal cohort included 216 patients. The final logistic regression model included the following variables: INCREMENT-CPE mortality score ≥8 (8 points), no source control (3points), inappropriate empirical therapy (2 points), cytomegalovirus disease (7 points), lymphopenia (4 points), and the interaction between INCREMENT-CPE score ≥8 and CMV disease (minus 7 points). This score showed an area under the receiver operatng characteristic curve of 0.82 (95% confidence interval [CI] 0.76-0.88) and classified patients into 3 strata: 0-7 (low mortality), 8-11 (high mortality), and 12-17 (very-high mortality). We performed a stratified analysis of the effect of monotherapy vs combination therapy among 165 patients who received appropriate therapy. Monotherapy was associated with higher mortality only in the very-high (adjusted hazard ratio [HR] 2.82, 95% CI 1.13-7.06, P = .03) and high (HR 9.93, 95% CI 2.08-47.40, P = .004) mortality risk strata. A score-based algorithm is provided for therapy guidance. |
Cita | Pérez Nadales, E., Gutiérrez Gutiérrez, B., Natera, A.M., Abdala, E., Magalhães, M.R., Mularoni, A.,...,REIPI/INCREMENT-SOT Investigators, (2020). Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia. american Journal of Transplantation, 20 (6), 1629-1641. https://doi.org/10.1111/ajt.15769. |